The European CNS Summit 2016 will build on the success of the 4th annual World CNS Summit 2016, with an exclusive focus on empowering translational research in the field of neurodegeneration.
This is a unique opportunity to engage with the thought leaders in the neurodegenerative space from academia, pharma, biotech and leading consortia to advance the successful development of the next generation of therapies.
Use this collaborative format to address key challenges facing this field from the translatability of modelling systems to the development of cost effective, non-invasive biomarkers and novel therapeutic strategies for targeting neurodegeneration.
“Essentially every speaker was excellent. A very informative and thought provoking series of presentations.”
Patricia Walicke, Medical Officer, National Institute Neurologic Disease and Stroke
- World CNS Attendee